Clinical Use of Everolimus-eluting Bioresorbable Vascular Scaffold (BVS) In Treating Coronary Artery Disease
Angioplasty Summits
Saved in:
Main Authors: | Liang, M, Kajiya T., Lee, C.-H., Chan M, Teo, S.G., Chan, K.H., Tan, H.C., Low, A |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/123978 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Initial experience in the clinical use of everolimus-eluting bioresorbable vascular scaffold (BVS) in a single institution
by: Liang, M., et al.
Published: (2014) -
Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)
by: Kajiya, T., et al.
Published: (2016) -
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
by: LOW, F, et al.
Published: (2021) -
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-Year results of a propensity score matching comparison: the BVS-examination study (Bioresorbable Vascular Scaffold-a clinical
by: Brugaletta, S., et al.
Published: (2016) -
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
by: Sotomi Y., et al.
Published: (2017)